{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:15:18Z","timestamp":1763572518256,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.medmal.2019.12.011","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T07:59:23Z","timestamp":1580889563000},"page":"658-664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Infections due to carbapenemase-producing bacteria, clinical burden, and impact of screening strategies on outcome"],"prefix":"10.1016","volume":"50","author":[{"given":"Louise","family":"Abramowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mich\u00e8le","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Martiny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Delforge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"De Wit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Konopnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.medmal.2019.12.011_bib0170","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"van Duin","year":"2016","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.medmal.2019.12.011_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/2295333714Y.0000000034","article-title":"Emergence and dissemination of multi-resistant Gram negative Enterobacteriaceae: lessons to be learnt from local and national surveillance programs in Belgium","volume":"70","author":"Rodriguez-Villalobos","year":"2015","journal-title":"Acta Clinica Belgica"},{"issue":"1","key":"10.1016\/j.medmal.2019.12.011_bib0180","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0035-1544208","article-title":"Carbapenemase-producing Enterobacteriaceae","volume":"36","author":"Doi","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.medmal.2019.12.011_bib0185","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: the Versatile \u03b2-Lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.medmal.2019.12.011_bib0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0213-005X(14)70168-5","article-title":"Carbapenemases in Enterobacteriaceae: types and molecular epidemiology","volume":"32","author":"Mart\u00ednez-Mart\u00ednez","year":"2014","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"2","key":"10.1016\/j.medmal.2019.12.011_bib0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":"Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study","volume":"17","author":"Grundmann","year":"2017","journal-title":"The Lancet Infectious Diseases"},{"issue":"3","key":"10.1016\/j.medmal.2019.12.011_bib0200","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/AAC.01020-07","article-title":"Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality","volume":"52","author":"Schwaber","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.medmal.2019.12.011_bib0205","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","article-title":"Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe","volume":"18","author":"Cant\u00f3n","year":"2012","journal-title":"Clinical Microbiology and Infection"},{"key":"10.1016\/j.medmal.2019.12.011_bib0210","unstructured":"Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention. [En ligne] https:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf. Accessed on August 10, 2017."},{"issue":"4","key":"10.1016\/j.medmal.2019.12.011_bib0215","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/21505594.2017.1306621","article-title":"Carbapenem-resistant Enterobacteriaceae: what we know and what we need to know","volume":"8","author":"van duin","year":"2017","journal-title":"Virulence"},{"issue":"4","key":"10.1016\/j.medmal.2019.12.011_bib0220","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.medmal.2019.12.011_bib0225","unstructured":"WHO | Antimicrobial resistance: global report on surveillance 2014. World Health Organization. [En ligne] http:\/\/www.who.int\/drugresistance\/documents\/surveillancereport\/en\/Accessed on September 14, 2017."},{"issue":"10","key":"10.1016\/j.medmal.2019.12.011_bib0230","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3855\/jidc.8231","article-title":"Risk factors for hospital infections caused by carbapanem-resistant Acinetobacter baumannii","volume":"10","author":"Djordjevic","year":"2016","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"10.1016\/j.medmal.2019.12.011_bib0235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4236\/aid.2013.31002","article-title":"Patient Demographics and Characteristics of Infection with Carbapenem-Resistant Acinetobacter baumannii in a Teaching Hospital from the United States","volume":"3","author":"Vaze","year":"2013","journal-title":"Advances in Infectious Diseases"},{"issue":"10","key":"10.1016\/j.medmal.2019.12.011_bib0240","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3109\/00365548.2010.489568","article-title":"Nosocomial imipenem-resistant Acinetobacter baumannii infections: Epidemiology and risk factors","volume":"42","author":"Dizday","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medmal.2019.12.011_bib0245","doi-asserted-by":"crossref","first-page":"305784","DOI":"10.1155\/2014\/305784","article-title":"Epidemiology of Carbapenemase-Producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean Countries","volume":"2014","author":"Djahmi","year":"2014","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.medmal.2019.12.011_bib0250","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13","author":"Munoz-Price","year":"2013","journal-title":"The Lancet Infectious Diseases"},{"issue":"4","key":"10.1016\/j.medmal.2019.12.011_bib0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0213-005X(14)70169-7","article-title":"Epidemiology of infections caused by carbapenemase-producing Enterobacteriaceae: reservoirs and transmission mechanisms","volume":"32","author":"L\u00f3pez-Cerero","year":"2014","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"9","key":"10.1016\/j.medmal.2019.12.011_bib0260","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/1469-0691.12719","article-title":"The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide","volume":"20","author":"Nordmann","year":"2014","journal-title":"Clinical Microbiology and Infection"},{"issue":"26.","key":"10.1016\/j.medmal.2019.12.011_bib0265","article-title":"Rapid emergence of carbapenemase-producing Enterobacteriaceae isolates in Belgium","volume":"16","author":"Huang","year":"2011","journal-title":"Euro Surveill"},{"issue":"45.","key":"10.1016\/j.medmal.2019.12.011_bib0270","article-title":"Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015","volume":"20","author":"Albiger","year":"2015","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.medmal.2019.12.011_bib0275","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/jac\/dkt096","article-title":"Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium","volume":"68","author":"Huang","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"19","key":"10.1016\/j.medmal.2019.12.011_bib0280","doi-asserted-by":"crossref","first-page":"30530","DOI":"10.2807\/1560-7917.ES.2017.22.19.30530","article-title":"Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015","volume":"22","author":"Huang","year":"2017","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.medmal.2019.12.011_bib0285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/dkq388","article-title":"Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals","volume":"66","author":"Rodriguez Villalobos","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2019.12.011_bib0290","unstructured":"Charlson Comorbidity Index (CCI). MDCalc\u2013Medical calculators, equations, equations, algorithms, and scores. 2017. [En ligne] https:\/\/www.mdcalc.com\/charlson-comorbidity-index-cci. Accessed on December 17, 2019."},{"issue":"7","key":"10.1016\/j.medmal.2019.12.011_bib0295","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study","volume":"17","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"The Lancet Infectious Diseases"},{"issue":"7","key":"10.1016\/j.medmal.2019.12.011_bib0300","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AAC.02636-14","article-title":"Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network","volume":"58","author":"van Duin","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"14","key":"10.1016\/j.medmal.2019.12.011_bib0305","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.2015.12480","article-title":"Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013","volume":"314","author":"Guh","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.medmal.2019.12.011_bib0310","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/CCM.0000000000001028","article-title":"The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study","volume":"43","author":"Dautzenberg","year":"2015","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.medmal.2019.12.011_bib0315","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/00365548.2011.638318","article-title":"Over-treatment of carbapenemase-producing Enterobacteriaceae","volume":"44","author":"Rihani","year":"2012","journal-title":"Scan J Infect Dis"},{"issue":"2","key":"10.1016\/j.medmal.2019.12.011_bib0320","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jinf.2015.10.008","article-title":"Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain","volume":"72","author":"Palacios-Baena","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2019.12.011_bib0325","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13756-017-0182-3","article-title":"The sink as a potential source of transmission of carbapenemase-producing Enterobacteriaceae in the intensive care unit","volume":"6","author":"De Geyter","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"issue":"2","key":"10.1016\/j.medmal.2019.12.011_bib0330","first-page":"1","article-title":"Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections","volume":"2","author":"Morril","year":"2015","journal-title":"Open Forum Infect Dis"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X2030024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X2030024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:19:29Z","timestamp":1759972769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X2030024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0399077X2030024X"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2019.12.011","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections due to carbapenemase-producing bacteria, clinical burden, and impact of screening strategies on outcome","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2019.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}